RPID Key Statistics, Chart & Performance
The current stock price of RPID is 4.17 USD. In the past month the price increased by 42.32%. In the past year, price increased by 262.61%.
RPID Latest News, Press Relases and Analysis
RPID Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 26.23 | 221.84B | ||
| DHR | DANAHER CORP | 29.49 | 162.82B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 182.53 | 55.39B | ||
| A | AGILENT TECHNOLOGIES INC | 27.75 | 42.88B | ||
| IQV | IQVIA HOLDINGS INC | 19.34 | 38.23B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 34.71 | 29.92B | ||
| WAT | WATERS CORP | 31.02 | 23.45B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 38.34 | 19.49B | ||
| ILMN | ILLUMINA INC | 28.41 | 19.04B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.39 | 16.67B | ||
| TEM | TEMPUS AI INC | N/A | 12.21B | ||
| RVTY | REVVITY INC | 20.52 | 11.41B |
Related stock screener links
About RPID
Company Profile
Rapid Micro Biosystems, Inc. is a life sciences technology company. The company is headquartered in Lexington, Massachusetts and currently employs 163 full-time employees. The company went IPO on 2021-07-15. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. The company offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Company Info
RAPID MICRO BIOSYSTEMS INC-A
25 Hartwell Avenue
Lexington MASSACHUSETTS US
CEO: Robert Spignesi
Employees: 163
Phone: 19783493200
RAPID MICRO BIOSYSTEMS INC-A / RPID FAQ
Can you describe the business of RAPID MICRO BIOSYSTEMS INC-A?
Rapid Micro Biosystems, Inc. is a life sciences technology company. The company is headquartered in Lexington, Massachusetts and currently employs 163 full-time employees. The company went IPO on 2021-07-15. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. The company offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
What is the stock price of RAPID MICRO BIOSYSTEMS INC-A today?
The current stock price of RPID is 4.17 USD. The price increased by 2.71% in the last trading session.
Does RPID stock pay dividends?
RPID does not pay a dividend.
What is the ChartMill rating of RAPID MICRO BIOSYSTEMS INC-A stock?
RPID has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the analyst forecast for RPID stock?
10 analysts have analysed RPID and the average price target is 8.16 USD. This implies a price increase of 95.68% is expected in the next year compared to the current price of 4.17.
What is the employee count for RPID stock?
RAPID MICRO BIOSYSTEMS INC-A (RPID) currently has 163 employees.
What is the next earnings date for RPID stock?
RAPID MICRO BIOSYSTEMS INC-A (RPID) will report earnings on 2026-02-26, after the market close.
RPID Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to RPID. When comparing the yearly performance of all stocks, RPID is one of the better performing stocks in the market, outperforming 98.64% of all stocks.
RPID Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RPID. RPID may be in some trouble as it scores bad on both profitability and health.
RPID Financial Highlights
Over the last trailing twelve months RPID reported a non-GAAP Earnings per Share(EPS) of -1.01. The EPS increased by 9.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -58.36% | ||
| ROE | -80.87% | ||
| Debt/Equity | 0 |
RPID Forecast & Estimates
10 analysts have analysed RPID and the average price target is 8.16 USD. This implies a price increase of 95.68% is expected in the next year compared to the current price of 4.17.
For the next year, analysts expect an EPS growth of 6.97% and a revenue growth 15.94% for RPID